Frontiers in Pharmacology | Gastrointestinal and Hepatic Pharmacology

Systematic Review

Published on 18 Jun 2025

Knowledge graph and emerging trends in oxidative stress research on hepatic ischemia-reperfusion injury: a bibliometric analysis (1995–2024)

in Gastrointestinal and Hepatic Pharmacology

Simeng Lei
Yangkai Fu
Bo Zhang
Hanwen Yang
Zhili Ji

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1587591

152 views

Original Research

Published on 18 Jun 2025

Short-term high-fat diet feeding plus acute ethanol binge induced acute liver injury in mice via oxidative stress, inflammation and pyroptosis

in Gastrointestinal and Hepatic Pharmacology

Yao Deng
Xinling Chen
Wenhai Guo
Yun Chen
Luyao Xu
Wenting Suo
Wei Liu
Jiaying Dai
Kangrong Wang
Qiuling Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1602280

211 views

Original Research

Published on 18 Jun 2025

Octreotide combined with pantoprazole in the treatment of elderly patients with peptic ulcer complicated by upper gastrointestinal bleeding

in Gastrointestinal and Hepatic Pharmacology

Ming Yang
Shu-Qin Zhang
Jing Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1623530

159 views

Correction

Published on 17 Jun 2025

Correction: Andrographis paniculata restores gut health by suppressing inflammation and strengthening mucosal immunity

in Gastrointestinal and Hepatic Pharmacology

Vidushi Tyagi
Ashish Kumar
Karuna Shanker
Anirban Pal

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1637737

247 views

Correction

Accepted on 16 Jun 2025

Corrigendum: Paricalcitol alleviates intestinal ischemia-reperfusion injury via inhibition of the ATF4-CHOP pathway

in Gastrointestinal and Hepatic Pharmacology

嘉伟张
Tingting Liu
Tongqing Xue
Zhongzhi Jia

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1632205

Original Research

Accepted on 13 Jun 2025

Pharmacological Basis for Medicinal Use of Cymbopogon proximus Hochst. ex A. Rich. Essential Oil in Hyperactive Gastrointestinal Disorders

in Gastrointestinal and Hepatic Pharmacology

Hassan N. Althurwi
Najeeb Ur Rehman
Maged Abdel-Kader
Faisal F. Albaqami

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533511

Correction

Accepted on 12 Jun 2025

Correction: Exploring the lutein therapeutic potential in steatotic liver disease: mechanistic insights and future directions

in Gastrointestinal and Hepatic Pharmacology

Elisa Balboa
Faride Saud
Claudia Parra-Ruiz
Marjorie De La Fuente
Glauben Tamara Landskron
Silvana Zanlungo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1633575

Original Research

Published on 11 Jun 2025

Dihydroartemisinin-sodium taurocholate-PLGA nanoparticles: a novel therapeutic approach against cystic echinococcosis

in Gastrointestinal and Hepatic Pharmacology

Aierpati Moheteer
Jiang Zhu
Dongming Pang
Xue Rao
Nijiati Aini
Kalibixiati Aimulajiang
Zhenping Zhang
Saifuding Abula
Adelijiang Wusiman

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1600525

436 views

Systematic Review

Accepted on 10 Jun 2025

Effect of serum MMP-7 on the diagnostic accuracy of biliary atresia: Systematic review and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Haojun Wang
Hui Liu
Wanfu Li
Ainiwaer Keranmu
Peng Liang
Yaqi Wang
Tao Zhang
Yeliaman Jiayilawu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1581053

121 views

Original Research

Accepted on 09 Jun 2025

D-glucaro-1,4-lactone Alleviates Acetaminophen-Induced Hepatotoxicity in Mice via Modulating Gut Microbiota and Metabolites Associated with Lactobacillus-Glutamine and Nicotinic Acid Pathways

in Gastrointestinal and Hepatic Pharmacology

Zhiying Song
Yiran Pan
Zeyu Wang
Yujing Chen
Yufeng Deng
Lele Wang
Qi Hu
Wenxiang Huang
Shuilin Sun
Baogang Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1627850

101 views

Original Research

Published on 09 Jun 2025

Protective role of remogliflozin against experimental liver fibrosis by activating AMPK/SIRT1/Nrf2 and suppressing NF-κB pathways

in Gastrointestinal and Hepatic Pharmacology

Naif ALSuhaymi
Mahdi H. Alsugoor
Aya A. Shokry
Hany M. Fayed
Bassim M. S. A. Mohamed
Sherif M. Afifi
Tuba Esatbeyoglu
Reda M. S. Korany
Marawan A. Elbaset

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1586231

750 views

Original Research

Published on 06 Jun 2025

A pathology-attention multi-instance learning framework for multimodal classification of colorectal lesions

in Gastrointestinal and Hepatic Pharmacology

Fanglei Fu
Xeimei Zhang
Zhaoxuan Wang
Luxi Xie
Mingxi Fu
Jing Peng
Jianfeng Wu
Zhe Wang
Tian Guan
Yonghong He

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1592950

460 views

Original Research

Accepted on 04 Jun 2025

The changes of metabolites in AP patients

in Gastrointestinal and Hepatic Pharmacology

Meng-Yan Cui
Miao-Yan Fan
Su-Min Chen
Meng-Qi Zhao
Qiao-Li Jiang
Jing-Jing Wang
Yue Zeng
Yu Zhao
Ying-Ying Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1614713

Original Research

Published on 04 Jun 2025

Real-world data of Azvudine-induced hepatotoxicity among hospitalized COVID-19 patients in China: a retrospective case-control study

in Gastrointestinal and Hepatic Pharmacology

Yuanguo Xiong
Hao Xin
Cai Shi
Xianxi Guo
Ying Chen
Caifei Huang
Fuwang Ma
Ge Yang
Jian Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558054

809 views

Editorial

Published on 04 Jun 2025

Editorial: Microbiome: the modulator of human health

in Gastrointestinal and Hepatic Pharmacology

Ji Youn Yoo
Moumita Dutta

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1625412

938 views

Original Research

Published on 03 Jun 2025

Role of gut microbiota in bempedoic acid against hyperlipidemia: a new candidate target for bempedoic acid on the therapeutic regulation

in Gastrointestinal and Hepatic Pharmacology

Wei-Jian Zhang
Jian Wang
Zi-Qi Ouyang
Sen-Rong Luo
Zhi-Kai Chen
Yuan-Kang He
Mu-Jin Luo
Xu-Xing Liao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1584273

768 views